To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
25 Current news from ireland
rss
Raman spectroscopic mapping for the analysis of solar radiation induced skin damage
10-04-2013
Working with an artificial skin model exposed to simulated solar irradiation, scientists in Ireland used Raman spectroscopic mapping to identify the dermal and stratum corneum layers in samples and distinguish further substructures of the epidermis. The authors were able to identify DNA ...
Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
28-08-2012
Janssen Biologics announced it has initiated the Phase 3 development program for sirukumab (CNTO 136) as part of a collaboration with GlaxoSmithKline plc (GSK). Sirukumab is a human anti-interleukin (IL)-6 monoclonal antibody being studied for the treatment of adults with moderately to ...
Genzyme gets Regulatory Approvals of Expanded Waterford Manufacturing Plant
03-05-2012
Genzyme, a Sanofi company, announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved a second suite for filling and finishing product at its Waterford, Ireland manufacturing plant. With this approval, Genzyme has nearly doubled its ability to ...
Univar Ireland has been awarded the Good Distributor Practice (GDP) Passport
15-02-2012
Univar Inc. announced that Univar Ireland has been awarded the Good Distributor Practice (GDP) Passport for its pharmaceutical and medical device businesses. The accolade was awarded jointly by the Irish Exporters Association and Life Science, Ireland. The GDP Passport is the first of its ...
'Speed gene' in modern racehorses originated from British mare 300 years ago, scientists say
26-01-2012
Scientists have traced the origin of the 'speed gene' in Thoroughbred racehorses back to a single British mare that lived in the United Kingdom around 300 years ago, according to findings published in Nature Communications.The origin of the 'speed gene' (C type myostatin gene variant) was ...
Amarin Corporation Appoints Paul E. Huff as Chief Commercial Officer
07-02-2011
Amarin Corporation plc announced that Paul E. Huff has joined the Company as Chief Commercial Officer. In this role, Mr. Huff is responsible for driving Amarin’s AMR101 commercialization strategy, including all marketing and sales planning and implementation, including product launch ...
Amarin Corporation Appoints Kristine Peterson to Board of Directors
22-11-2010
Amarin Corporation plc announced the appointment of Kristine Peterson to its board of directors. Ms. Peterson has more than 27 years of pharmaceutical industry experience, including 20 years at Bristol-Myers Squibb, where she was responsible for sales, marketing and general management in a ...
Amarin corporation announces senior management changes
11-11-2010
Amarin Corporation plc announced that, effective November 10, 2010, Joseph S. Zakrzewski has been appointed Chief Executive Officer. Mr. Zakrzewski has served as the Chairman of the Board of Amarin since January 2010 and will continue to serve in that capacity. Mr. Zakrzewski has more than ...
Amarin corporation Appoints Colin W. Stewart as President and Chief Executive Officer
18-08-2010
Amarin Corporation plc announced that Colin W. Stewart has been appointed President, Chief Executive Officer (CEO) and a member of the Company’s Board of Directors effective August 16, 2010. Mr. Stewart will be responsible for driving forward the Company’s strategy to maximize the value of ...
Amarin’s AMR101 pivotal phase 3 MARINE clinical trial completes patient enrollment and randomization
11-08-2010
Amarin Corporation plc announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part ...
Netmeeting
